Bunge soybean oil heart health claim approved by US FDA

3108501e-9fca-4acf-b363-32b2d795bdccarticleimage.jpg

01 Aug 2017 --- The US Food and Drug Administration (FDA) has approved Bunge North America’s petition for a qualified health claim linking soybean oil consumption to reduced risk of heart disease. Soybean oil is the US’ most commonly used ingredient and top dietary source of polyunsaturated fats.

Bunge reports that it independently filed a petition with the FDA that included a summary of recent major clinical studies showing the potential benefits of soybean oil to heart health based on its demonstrated positive effect on cholesterol levels and its high concentration of polyunsaturated omega 6 and omega 3 fatty acids versus other oils and fats. 

Click to EnlargeCompanies can now communicate that soybean oil may reduce heart disease risk and lower LDL-cholesterol when replacing saturated fat and not increasing calories.

“Bunge is committed to enhancing the value of America’s most accessible food oil,” says Dr. Mark Stavro, Senior Director of Marketing, Bunge North America. “The FDA’s decision provides opportunities for food companies to develop more heart healthy products, for consumers looking to improve their heart health and for soybean farmers who thrive when demand for their crop increases.”

The US is the world’s leading soybean producer, accounting for 33 percent of global production. Bunge is a leading soybean oil producer globally and works closely with soybean farmers in the US and other regions to turn their harvests into oils that are foundational part of many people’s diet.

“We take great pride in the trusted relationships we have with our farmer-customers and work hard to develop new markets for their crops,” says Timothy Gallagher, Executive Vice President, oilseed value chain, Bunge North America. “By promoting soybean oil’s heart health benefits, we are helping to drive demand for a high quality product that can benefit the full soybean value chain.”

Related Articles

Nutrition & Health News

AI: Nuritas explores potential health benefits during Future of Nutrition Summit

13 Dec 2017 --- Biotechnology company Nuritas has innovative plans for using artificial intelligence (AI) to relieve the potential burden of future global health issues. These plans were outlined during its Future of Nutrition Summit held the day before FiE 2017 in Frankfurt, during which Nuritas Commercial Manager Neil Foster outlined the company’s use of AI for data mining for bioactive peptides, specific molecules with “tremendous” health benefits.

Business News

Vitafoods Europe to examine mainstreaming of personalized nutrition

13 Dec 2017 --- One of the major issues to be discussed at Vitafoods Europe 2018 will be how personalized nutrition can break out of its niche and achieve mass market appeal, the organizers of the global nutraceutical event have announced. Advances in genomics and wearable technology have created new opportunities for products tailored to individual consumers. And in a new poll conducted by the organizers, personalized nutrition ranks as one of the most important industry trends for 2018, behind only clean label and scientifically supported health claims.

Business News

Scientists find natural mimetics of anti-cancer and anti-aging drugs

04 Dec 2017 --- Researchers from the Biogerontology Research Foundation in the UK, Insilico Medicine, Life Extension and other institutions have announced the publication of a landmark study in the journal Aging on the identification of natural mimetics of metformin and rapamycin.

Nutrition & Health News

Low-salt and DASH diet as effective as drugs for some adults with high blood pressure: study

23 Nov 2017 --- A study of adults with prehypertension, or stage 1 high blood pressure, has shown that combining a low-salt diet with the heart-healthy DASH diet substantially lowers systolic blood pressure – the top number in a blood pressure test – especially in people with higher baseline systolic readings.

Nutrition & Health News

Four claims in one vegan capsule: Polaris launches algal DHA omega 3 in softgel

21 Nov 2017 --- Polaris is launching its ultra-stable algal DHA omega 3 in vegan softgel format, enabling it to offer four EFSA claims in one capsule, the company reports. Each capsule is said to deliver an optimal 250mg of DHA omega 3 from microalgae in a 100 percent plant-based shell, making it the ideal solution for consumers seeking a vegan or vegetarian alternative to gelatin capsules.

More Articles
URL : http://www.nutritioninsight.com:80/news/bunge-soybean-oil-heart-health-claim-approved-by-us-fda.html